

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of sequestering of triglyceride (GO:0010889) | 8.86016468 |
| 2 | white fat cell differentiation (GO:0050872) | 8.77849089 |
| 3 | triglyceride catabolic process (GO:0019433) | 8.72852971 |
| 4 | brown fat cell differentiation (GO:0050873) | 7.97506123 |
| 5 | valine metabolic process (GO:0006573) | 7.86967354 |
| 6 | acylglycerol catabolic process (GO:0046464) | 7.83441742 |
| 7 | neutral lipid catabolic process (GO:0046461) | 7.83441742 |
| 8 | biotin metabolic process (GO:0006768) | 6.50288924 |
| 9 | regulation of cholesterol storage (GO:0010885) | 6.08274126 |
| 10 | lipid particle organization (GO:0034389) | 6.02596369 |
| 11 | glycerolipid catabolic process (GO:0046503) | 5.86208307 |
| 12 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 5.81970323 |
| 13 | triglyceride biosynthetic process (GO:0019432) | 5.52124693 |
| 14 | positive regulation of fatty acid oxidation (GO:0046321) | 5.40718638 |
| 15 | acylglycerol biosynthetic process (GO:0046463) | 5.25500134 |
| 16 | neutral lipid biosynthetic process (GO:0046460) | 5.25500134 |
| 17 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 5.18109482 |
| 18 | fatty acid transmembrane transport (GO:1902001) | 5.16008876 |
| 19 | branched-chain amino acid metabolic process (GO:0009081) | 5.03478262 |
| 20 | branched-chain amino acid catabolic process (GO:0009083) | 4.87367557 |
| 21 | lipid storage (GO:0019915) | 4.83215794 |
| 22 | protein heterotrimerization (GO:0070208) | 4.70520265 |
| 23 | negative regulation of protein autophosphorylation (GO:0031953) | 4.63959833 |
| 24 | carnitine shuttle (GO:0006853) | 4.60113493 |
| 25 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 4.58719448 |
| 26 | fatty acid beta-oxidation (GO:0006635) | 4.53172476 |
| 27 | cellular response to lithium ion (GO:0071285) | 4.50605853 |
| 28 | triglyceride metabolic process (GO:0006641) | 4.49681457 |
| 29 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.39509942 |
| 30 | acyl-CoA biosynthetic process (GO:0071616) | 4.32689538 |
| 31 | thioester biosynthetic process (GO:0035384) | 4.32689538 |
| 32 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.32673763 |
| 33 | negative regulation of granulocyte differentiation (GO:0030853) | 4.32021322 |
| 34 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.28710846 |
| 35 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 4.26408206 |
| 36 | negative regulation of phagocytosis (GO:0050765) | 4.24630016 |
| 37 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.23201093 |
| 38 | acylglycerol metabolic process (GO:0006639) | 4.22508261 |
| 39 | regulation of glycogen (starch) synthase activity (GO:2000465) | 4.21275295 |
| 40 | positive regulation of glomerulus development (GO:0090193) | 4.20167593 |
| 41 | positive regulation of fatty acid metabolic process (GO:0045923) | 4.16836981 |
| 42 | neutral lipid metabolic process (GO:0006638) | 4.16667927 |
| 43 | plasma lipoprotein particle clearance (GO:0034381) | 4.15508802 |
| 44 | negative regulation of lipid storage (GO:0010888) | 4.14644633 |
| 45 | fatty acid oxidation (GO:0019395) | 4.10349522 |
| 46 | coenzyme A biosynthetic process (GO:0015937) | 4.07508754 |
| 47 | lipid oxidation (GO:0034440) | 4.02341777 |
| 48 | regulation of fatty acid oxidation (GO:0046320) | 4.02171105 |
| 49 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.01655319 |
| 50 | pentose-phosphate shunt (GO:0006098) | 4.01366261 |
| 51 | fatty acid homeostasis (GO:0055089) | 4.00292761 |
| 52 | NADPH regeneration (GO:0006740) | 3.98278639 |
| 53 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.97805910 |
| 54 | positive regulation of lipid catabolic process (GO:0050996) | 3.95129620 |
| 55 | alpha-linolenic acid metabolic process (GO:0036109) | 3.94159571 |
| 56 | cellular response to epinephrine stimulus (GO:0071872) | 3.88917931 |
| 57 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.88496570 |
| 58 | fatty acid catabolic process (GO:0009062) | 3.87036479 |
| 59 | positive regulation of glucose import (GO:0046326) | 3.87031775 |
| 60 | negative regulation of macrophage differentiation (GO:0045650) | 3.86810917 |
| 61 | positive regulation of cholesterol efflux (GO:0010875) | 3.84514157 |
| 62 | response to dietary excess (GO:0002021) | 3.83609752 |
| 63 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.81165928 |
| 64 | positive regulation of lipid storage (GO:0010884) | 3.80623581 |
| 65 | positive regulation of cholesterol transport (GO:0032376) | 3.79897162 |
| 66 | positive regulation of sterol transport (GO:0032373) | 3.79897162 |
| 67 | tricarboxylic acid metabolic process (GO:0072350) | 3.76463683 |
| 68 | carnitine transmembrane transport (GO:1902603) | 3.76101492 |
| 69 | negative regulation of metanephros development (GO:0072217) | 3.74408148 |
| 70 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.74217370 |
| 71 | response to peptidoglycan (GO:0032494) | 3.74202994 |
| 72 | oxaloacetate metabolic process (GO:0006107) | 3.73719642 |
| 73 | neutrophil activation involved in immune response (GO:0002283) | 3.72999705 |
| 74 | negative regulation of DNA biosynthetic process (GO:2000279) | 3.72435130 |
| 75 | growth hormone receptor signaling pathway (GO:0060396) | 3.72003964 |
| 76 | negative regulation of gluconeogenesis (GO:0045721) | 3.71532301 |
| 77 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.70538675 |
| 78 | acetyl-CoA metabolic process (GO:0006084) | 3.68678234 |
| 79 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.61531813 |
| 80 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.57304872 |
| 81 | regulation of triglyceride catabolic process (GO:0010896) | 3.57030975 |
| 82 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 3.49835620 |
| 83 | L-serine transport (GO:0015825) | 3.49213149 |
| 84 | regulation of triglyceride metabolic process (GO:0090207) | 3.47550181 |
| 85 | amino-acid betaine transport (GO:0015838) | 3.47185832 |
| 86 | carnitine transport (GO:0015879) | 3.47185832 |
| 87 | cellular extravasation (GO:0045123) | 3.46854352 |
| 88 | barbed-end actin filament capping (GO:0051016) | 3.45406494 |
| 89 | regulation of lipid storage (GO:0010883) | 3.45165051 |
| 90 | cellular response to growth hormone stimulus (GO:0071378) | 3.44276241 |
| 91 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.43278311 |
| 92 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.42418153 |
| 93 | fat cell differentiation (GO:0045444) | 3.40703707 |
| 94 | negative regulation of interleukin-12 production (GO:0032695) | 3.35183861 |
| 95 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.35146933 |
| 96 | positive regulation of glucose transport (GO:0010828) | 3.31945311 |
| 97 | regulation of receptor binding (GO:1900120) | 3.31163958 |
| 98 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.30256462 |
| 99 | positive regulation of calcium ion import (GO:0090280) | 3.28340386 |
| 100 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.26040897 |
| 101 | regulation of growth of symbiont in host (GO:0044126) | 3.26040897 |
| 102 | negative regulation of growth of symbiont in host (GO:0044130) | 3.26040897 |
| 103 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.26040897 |
| 104 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.22827843 |
| 105 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.22167007 |
| 106 | 2-oxoglutarate metabolic process (GO:0006103) | 3.18351282 |
| 107 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.18094073 |
| 108 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.16849159 |
| 109 | coenzyme A metabolic process (GO:0015936) | 3.15536115 |
| 110 | transcytosis (GO:0045056) | 3.14753472 |
| 111 | intracellular lipid transport (GO:0032365) | 3.13538803 |
| 112 | diacylglycerol metabolic process (GO:0046339) | 3.13019893 |
| 113 | ovulation from ovarian follicle (GO:0001542) | 3.12930008 |
| 114 | regulation of chemokine biosynthetic process (GO:0045073) | 3.12619382 |
| 115 | regulation of mononuclear cell migration (GO:0071675) | 3.12455471 |
| 116 | regulation of gonadotropin secretion (GO:0032276) | 3.10071903 |
| 117 | response to epinephrine (GO:0071871) | 3.09974983 |
| 118 | macrophage activation involved in immune response (GO:0002281) | 3.07269851 |
| 119 | macrophage differentiation (GO:0030225) | 3.06619418 |
| 120 | immunoglobulin mediated immune response (GO:0016064) | 3.03463512 |
| 121 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.02244353 |
| 122 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.02244353 |
| 123 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.00244827 |
| 124 | detection of other organism (GO:0098543) | 2.99603176 |
| 125 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.99139586 |
| 126 | regulation of cellular extravasation (GO:0002691) | 2.95020118 |
| 127 | regulation of monocyte chemotaxis (GO:0090025) | 2.93907794 |
| 128 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.90171956 |
| 129 | modulation by symbiont of host defense response (GO:0052031) | 2.89541464 |
| 130 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.89541464 |
| 131 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.89541464 |
| 132 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.89541464 |
| 133 | modulation by symbiont of host immune response (GO:0052553) | 2.89541464 |
| 134 | positive regulation by symbiont of host defense response (GO:0052509) | 2.89541464 |
| 135 | detection of bacterium (GO:0016045) | 2.84237377 |
| 136 | negative regulation of norepinephrine secretion (GO:0010700) | 2.78459599 |
| 137 | neutrophil mediated immunity (GO:0002446) | 2.77860381 |
| 138 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.72723613 |
| 139 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.69101270 |
| 140 | reactive oxygen species biosynthetic process (GO:1903409) | 2.69040753 |
| 141 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.67885808 |
| 142 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.66346764 |
| 143 | microglial cell activation (GO:0001774) | 2.65658269 |
| 144 | regulation of tumor necrosis factor production (GO:0032680) | 2.65143994 |
| 145 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.64393969 |
| 146 | negative regulation of cell killing (GO:0031342) | 2.63044972 |
| 147 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.63044972 |
| 148 | angiotensin maturation (GO:0002003) | 2.62652696 |
| 149 | response to hydroperoxide (GO:0033194) | 2.60654623 |
| 150 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.56593820 |
| 151 | macrophage activation (GO:0042116) | 2.56543936 |
| 152 | keratan sulfate catabolic process (GO:0042340) | 2.56386861 |
| 153 | mannose metabolic process (GO:0006013) | 2.56165919 |
| 154 | detection of external biotic stimulus (GO:0098581) | 2.55954356 |
| 155 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.55191498 |
| 156 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.54228682 |
| 157 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.52916846 |
| 158 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.52651112 |
| 159 | regulation of macrophage chemotaxis (GO:0010758) | 2.51582646 |
| 160 | mature B cell differentiation involved in immune response (GO:0002313) | 2.51343206 |
| 161 | regulation of gamma-delta T cell activation (GO:0046643) | 2.50821028 |
| 162 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.50744835 |
| 163 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.48689597 |
| 164 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.47553372 |
| 165 | regulation of mast cell degranulation (GO:0043304) | 2.46385758 |
| 166 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.46318525 |
| 167 | cellular response to type I interferon (GO:0071357) | 2.46069146 |
| 168 | type I interferon signaling pathway (GO:0060337) | 2.46069146 |
| 169 | response to muramyl dipeptide (GO:0032495) | 2.45800408 |
| 170 | regulation of monocyte differentiation (GO:0045655) | 2.44636486 |
| 171 | response to type I interferon (GO:0034340) | 2.43169411 |
| 172 | positive regulation of B cell differentiation (GO:0045579) | 2.42414926 |
| 173 | low-density lipoprotein particle clearance (GO:0034383) | 10.0541686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 6.57635673 |
| 2 | CLOCK_20551151_ChIP-Seq_293T_Human | 4.78929122 |
| 3 | * VDR_21846776_ChIP-Seq_THP-1_Human | 3.17826856 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.15945965 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.97769511 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.94441556 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.76506338 |
| 8 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.69620577 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.69239503 |
| 10 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.65835512 |
| 11 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.64948950 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.55412613 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.53346790 |
| 14 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 2.43294971 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.34413896 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.31144625 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.26869842 |
| 18 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.26713598 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.21532457 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.16629865 |
| 21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.08958621 |
| 22 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 2.01887278 |
| 23 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 15.2165354 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.96738730 |
| 25 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.92827348 |
| 26 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.85759345 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.80041492 |
| 28 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.75779530 |
| 29 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.75650050 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.70568383 |
| 31 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.70035358 |
| 32 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68522300 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.65467170 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.64813910 |
| 35 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.64386622 |
| 36 | SPI1_23127762_ChIP-Seq_K562_Human | 1.62104396 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.62011231 |
| 38 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.58711406 |
| 39 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56236778 |
| 40 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.55985901 |
| 41 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.51527229 |
| 42 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.51277730 |
| 43 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.50950900 |
| 44 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.49379646 |
| 45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.48801623 |
| 46 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47557526 |
| 47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44330902 |
| 48 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42182139 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.40725663 |
| 50 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.40355662 |
| 51 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.39026821 |
| 52 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.34708274 |
| 53 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.33819917 |
| 54 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.33312721 |
| 55 | MAF_26560356_Chip-Seq_TH1_Human | 1.33264294 |
| 56 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32099365 |
| 57 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.31875542 |
| 58 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.31875542 |
| 59 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.31541014 |
| 60 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.28037370 |
| 61 | UTX_26944678_Chip-Seq_JUKART_Human | 1.27973687 |
| 62 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27901638 |
| 63 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.27405021 |
| 64 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.24972081 |
| 65 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.24830432 |
| 66 | MAF_26560356_Chip-Seq_TH2_Human | 1.23979076 |
| 67 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22093878 |
| 68 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.21325663 |
| 69 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.21250338 |
| 70 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.16864801 |
| 71 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.16700399 |
| 72 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.14625497 |
| 73 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14408926 |
| 74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14203215 |
| 75 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.13330783 |
| 76 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11795427 |
| 77 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.11445634 |
| 78 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.10770113 |
| 79 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09754919 |
| 80 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07627235 |
| 81 | CJUN_26792858_Chip-Seq_BT549_Human | 1.07299572 |
| 82 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06686058 |
| 83 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.05944956 |
| 84 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05882212 |
| 85 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.05778992 |
| 86 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.05672230 |
| 87 | * P68_20966046_ChIP-Seq_HELA_Human | 1.04724896 |
| 88 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.04530827 |
| 89 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04462317 |
| 90 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.04014989 |
| 91 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03699688 |
| 92 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.03395630 |
| 93 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.00910254 |
| 94 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.98610845 |
| 95 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.98473529 |
| 96 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97774188 |
| 97 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.97189638 |
| 98 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.97186802 |
| 99 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95303907 |
| 100 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.95023569 |
| 101 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.94859073 |
| 102 | MYC_22102868_ChIP-Seq_BL_Human | 0.94430047 |
| 103 | SA1_27219007_Chip-Seq_Bcells_Human | 0.94200784 |
| 104 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.94142583 |
| 105 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.93984280 |
| 106 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.93648922 |
| 107 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.92976274 |
| 108 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90711624 |
| 109 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.88955916 |
| 110 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.87933370 |
| 111 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.86562114 |
| 112 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.86354431 |
| 113 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.86305195 |
| 114 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.84469064 |
| 115 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.84167585 |
| 116 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.81906869 |
| 117 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.81288984 |
| 118 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.81015118 |
| 119 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.80532925 |
| 120 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.79659720 |
| 121 | GATA1_19941826_ChIP-Seq_K562_Human | 0.79055998 |
| 122 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.78808080 |
| 123 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.77193153 |
| 124 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.76871187 |
| 125 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.76840120 |
| 126 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.76840120 |
| 127 | RXR_22108803_ChIP-Seq_LS180_Human | 0.76653058 |
| 128 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.76510886 |
| 129 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.76502442 |
| 130 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.76151870 |
| 131 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.73690684 |
| 132 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.73023698 |
| 133 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.70849684 |
| 134 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.70460805 |
| 135 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.70460805 |
| 136 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.68704252 |
| 137 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.67090111 |
| 138 | ATF3_27146783_Chip-Seq_COLON_Human | 0.66738828 |
| 139 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.66607785 |
| 140 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.65797768 |
| 141 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.65688128 |
| 142 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.65208180 |
| 143 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.64747461 |
| 144 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.64616361 |
| 145 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.64275654 |
| 146 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.63976375 |
| 147 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.63047705 |
| 148 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.62923391 |
| 149 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.61950776 |
| 150 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.61077042 |
| 151 | GATA2_19941826_ChIP-Seq_K562_Human | 0.60929099 |
| 152 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.59482568 |
| 153 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.59428959 |
| 154 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.56912631 |
| 155 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.55963894 |
| 156 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.55325465 |
| 157 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.54867306 |
| 158 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.54319441 |
| 159 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.54281954 |
| 160 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.54209684 |
| 161 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.53753951 |
| 162 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.53735753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 7.86044180 |
| 2 | MP0005666_abnormal_adipose_tissue | 5.63032784 |
| 3 | MP0004185_abnormal_adipocyte_glucose | 5.53924945 |
| 4 | MP0004130_abnormal_muscle_cell | 5.48203434 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 4.33137756 |
| 6 | MP0005375_adipose_tissue_phenotype | 4.09765954 |
| 7 | MP0003303_peritoneal_inflammation | 3.39575178 |
| 8 | MP0009278_abnormal_bone_marrow | 3.22882673 |
| 9 | MP0000013_abnormal_adipose_tissue | 3.13587506 |
| 10 | MP0002971_abnormal_brown_adipose | 3.06023506 |
| 11 | MP0005275_abnormal_skin_tensile | 3.05031814 |
| 12 | MP0002837_dystrophic_cardiac_calcinosis | 2.82104202 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.79966590 |
| 14 | MP0000003_abnormal_adipose_tissue | 2.71383304 |
| 15 | MP0003436_decreased_susceptibility_to | 2.65465491 |
| 16 | MP0009115_abnormal_fat_cell | 2.60205603 |
| 17 | MP0005397_hematopoietic_system_phenotyp | 2.50244685 |
| 18 | MP0001545_abnormal_hematopoietic_system | 2.50244685 |
| 19 | MP0005334_abnormal_fat_pad | 2.49692642 |
| 20 | MP0002876_abnormal_thyroid_physiology | 2.45014245 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.41186548 |
| 22 | * MP0002419_abnormal_innate_immunity | 2.18718655 |
| 23 | MP0009785_altered_susceptibility_to | 2.18498040 |
| 24 | MP0006082_CNS_inflammation | 2.17468936 |
| 25 | MP0003705_abnormal_hypodermis_morpholog | 2.17392003 |
| 26 | MP0001661_extended_life_span | 2.15485339 |
| 27 | MP0002970_abnormal_white_adipose | 2.13005480 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 2.05838473 |
| 29 | MP0003011_delayed_dark_adaptation | 2.04796326 |
| 30 | MP0002118_abnormal_lipid_homeostasis | 1.92179322 |
| 31 | * MP0005025_abnormal_response_to | 1.88341773 |
| 32 | MP0005000_abnormal_immune_tolerance | 1.84770222 |
| 33 | MP0001835_abnormal_antigen_presentation | 1.82603382 |
| 34 | MP0003724_increased_susceptibility_to | 1.79254206 |
| 35 | MP0003075_altered_response_to | 1.77461041 |
| 36 | MP0003959_abnormal_lean_body | 1.73440399 |
| 37 | MP0005535_abnormal_body_temperature | 1.72075973 |
| 38 | MP0004272_abnormal_basement_membrane | 1.69863180 |
| 39 | MP0009840_abnormal_foam_cell | 1.66646501 |
| 40 | MP0001790_abnormal_immune_system | 1.63779258 |
| 41 | MP0005387_immune_system_phenotype | 1.63779258 |
| 42 | MP0004510_myositis | 1.60947668 |
| 43 | MP0001853_heart_inflammation | 1.58384170 |
| 44 | MP0001881_abnormal_mammary_gland | 1.56982923 |
| 45 | MP0003828_pulmonary_edema | 1.54338195 |
| 46 | MP0003186_abnormal_redox_activity | 1.53644627 |
| 47 | MP0005448_abnormal_energy_balance | 1.53125665 |
| 48 | MP0006138_congestive_heart_failure | 1.44191391 |
| 49 | MP0002452_abnormal_antigen_presenting | 1.43236517 |
| 50 | MP0000604_amyloidosis | 1.42797318 |
| 51 | MP0000858_altered_metastatic_potential | 1.42382808 |
| 52 | MP0002723_abnormal_immune_serum | 1.39120257 |
| 53 | MP0005452_abnormal_adipose_tissue | 1.38133423 |
| 54 | MP0003300_gastrointestinal_ulcer | 1.35520032 |
| 55 | MP0000685_abnormal_immune_system | 1.35083663 |
| 56 | MP0002420_abnormal_adaptive_immunity | 1.33990278 |
| 57 | MP0002933_joint_inflammation | 1.33093529 |
| 58 | MP0001819_abnormal_immune_cell | 1.32598477 |
| 59 | MP0002796_impaired_skin_barrier | 1.31703202 |
| 60 | MP0003172_abnormal_lysosome_physiology | 1.31458220 |
| 61 | MP0002405_respiratory_system_inflammati | 1.31031808 |
| 62 | MP0009764_decreased_sensitivity_to | 1.30855266 |
| 63 | MP0001542_abnormal_bone_strength | 1.28534529 |
| 64 | MP0008775_abnormal_heart_ventricle | 1.28284762 |
| 65 | MP0000609_abnormal_liver_physiology | 1.28262034 |
| 66 | MP0001845_abnormal_inflammatory_respons | 1.27741332 |
| 67 | MP0004947_skin_inflammation | 1.27356405 |
| 68 | MP0002254_reproductive_system_inflammat | 1.26920803 |
| 69 | MP0008469_abnormal_protein_level | 1.24303357 |
| 70 | MP0002078_abnormal_glucose_homeostasis | 1.24181889 |
| 71 | MP0005671_abnormal_response_to | 1.23139823 |
| 72 | MP0005365_abnormal_bile_salt | 1.22551280 |
| 73 | MP0003690_abnormal_glial_cell | 1.22092219 |
| 74 | * MP0001800_abnormal_humoral_immune | 1.21590068 |
| 75 | MP0003279_aneurysm | 1.19094184 |
| 76 | MP0002060_abnormal_skin_morphology | 1.19020290 |
| 77 | MP0000343_altered_response_to | 1.16945977 |
| 78 | MP0003806_abnormal_nucleotide_metabolis | 1.12777362 |
| 79 | MP0001851_eye_inflammation | 1.12653420 |
| 80 | MP0004782_abnormal_surfactant_physiolog | 1.12113121 |
| 81 | MP0005390_skeleton_phenotype | 1.10947548 |
| 82 | MP0004883_abnormal_blood_vessel | 1.10574204 |
| 83 | MP0005464_abnormal_platelet_physiology | 1.10232055 |
| 84 | MP0009780_abnormal_chondrocyte_physiolo | 1.09364991 |
| 85 | MP0002166_altered_tumor_susceptibility | 1.08882134 |
| 86 | MP0003566_abnormal_cell_adhesion | 1.08133129 |
| 87 | MP0001501_abnormal_sleep_pattern | 1.07691122 |
| 88 | MP0003329_amyloid_beta_deposits | 1.05839159 |
| 89 | MP0005164_abnormal_response_to | 1.04218383 |
| 90 | MP0003453_abnormal_keratinocyte_physiol | 1.00266877 |
| 91 | MP0005165_increased_susceptibility_to | 0.98302084 |
| 92 | MP0003221_abnormal_cardiomyocyte_apopto | 0.98017231 |
| 93 | MP0005620_abnormal_muscle_contractility | 0.96147211 |
| 94 | MP0003045_fibrosis | 0.94252017 |
| 95 | MP0000751_myopathy | 0.93505439 |
| 96 | MP0000750_abnormal_muscle_regeneration | 0.91900709 |
| 97 | MP0001544_abnormal_cardiovascular_syste | 0.91477423 |
| 98 | MP0005385_cardiovascular_system_phenoty | 0.91477423 |
| 99 | MP0005503_abnormal_tendon_morphology | 0.88172275 |
| 100 | MP0008961_abnormal_basal_metabolism | 0.87996012 |
| 101 | MP0010155_abnormal_intestine_physiology | 0.87826204 |
| 102 | MP0003646_muscle_fatigue | 0.87800100 |
| 103 | MP0005166_decreased_susceptibility_to | 0.87632513 |
| 104 | MP0002909_abnormal_adrenal_gland | 0.86993550 |
| 105 | MP0001727_abnormal_embryo_implantation | 0.86477390 |
| 106 | MP0003950_abnormal_plasma_membrane | 0.84431144 |
| 107 | MP0004087_abnormal_muscle_fiber | 0.83813111 |
| 108 | MP0000716_abnormal_immune_system | 0.83426533 |
| 109 | MP0000759_abnormal_skeletal_muscle | 0.81441001 |
| 110 | MP0009333_abnormal_splenocyte_physiolog | 0.81009896 |
| 111 | MP0002006_tumorigenesis | 0.80756469 |
| 112 | MP0001756_abnormal_urination | 0.80672157 |
| 113 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.80379463 |
| 114 | MP0004858_abnormal_nervous_system | 0.78766590 |
| 115 | MP0004808_abnormal_hematopoietic_stem | 0.77000289 |
| 116 | MP0010234_abnormal_vibrissa_follicle | 0.76091992 |
| 117 | MP0002139_abnormal_hepatobiliary_system | 0.74775246 |
| 118 | MP0003948_abnormal_gas_homeostasis | 0.74428099 |
| 119 | MP0008260_abnormal_autophagy | 0.73314978 |
| 120 | MP0005319_abnormal_enzyme/_coenzyme | 0.73111602 |
| 121 | MP0001879_abnormal_lymphatic_vessel | 0.71857784 |
| 122 | MP0004147_increased_porphyrin_level | 0.71739547 |
| 123 | MP0008004_abnormal_stomach_pH | 0.71487713 |
| 124 | MP0001663_abnormal_digestive_system | 0.70449394 |
| 125 | MP0001177_atelectasis | 0.70239356 |
| 126 | MP0003953_abnormal_hormone_level | 0.70117047 |
| 127 | MP0002972_abnormal_cardiac_muscle | 0.69622222 |
| 128 | MP0006036_abnormal_mitochondrial_physio | 0.69617854 |
| 129 | MP0000249_abnormal_blood_vessel | 0.69511942 |
| 130 | MP0002168_other_aberrant_phenotype | 0.69333828 |
| 131 | MP0002638_abnormal_pupillary_reflex | 0.68985032 |
| 132 | MP0001764_abnormal_homeostasis | 0.68739555 |
| 133 | MP0002295_abnormal_pulmonary_circulatio | 0.68596576 |
| 134 | MP0009643_abnormal_urine_homeostasis | 0.68003130 |
| 135 | MP0001958_emphysema | 0.67571416 |
| 136 | MP0002332_abnormal_exercise_endurance | 0.65947657 |
| 137 | MP0005360_urolithiasis | 0.65298859 |
| 138 | MP0005332_abnormal_amino_acid | 0.62965566 |
| 139 | MP0005595_abnormal_vascular_smooth | 0.61804744 |
| 140 | MP0005388_respiratory_system_phenotype | 0.60723170 |
| 141 | MP0002133_abnormal_respiratory_system | 0.60723170 |
| 142 | MP0000230_abnormal_systemic_arterial | 0.59897721 |
| 143 | MP0005076_abnormal_cell_differentiation | 0.59771592 |
| 144 | MP0001533_abnormal_skeleton_physiology | 0.58809651 |
| 145 | MP0003448_altered_tumor_morphology | 0.55459878 |
| 146 | MP0005330_cardiomyopathy | 0.54144759 |
| 147 | MP0009763_increased_sensitivity_to | 0.53286335 |
| 148 | MP0009672_abnormal_birth_weight | 0.52922859 |
| 149 | MP0005058_abnormal_lysosome_morphology | 0.51353641 |
| 150 | MP0005167_abnormal_blood-brain_barrier | 0.49243779 |
| 151 | MP0005501_abnormal_skin_physiology | 0.49163772 |
| 152 | MP0005647_abnormal_sex_gland | 0.48551430 |
| 153 | MP0000427_abnormal_hair_cycle | 0.47113649 |
| 154 | MP0004036_abnormal_muscle_relaxation | 0.45573349 |
| 155 | MP0000627_abnormal_mammary_gland | 0.44141342 |
| 156 | MP0010630_abnormal_cardiac_muscle | 0.43846310 |
| 157 | MP0002998_abnormal_bone_remodeling | 0.43597117 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oligomenorrhea (HP:0000876) | 8.86189000 |
| 2 | Acanthosis nigricans (HP:0000956) | 7.34459423 |
| 3 | Hypertriglyceridemia (HP:0002155) | 6.46899816 |
| 4 | Hyperglycinuria (HP:0003108) | 5.47274157 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.13423247 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.13423247 |
| 7 | Abnormality of glycolipid metabolism (HP:0010969) | 5.13423247 |
| 8 | Difficulty running (HP:0009046) | 4.75387803 |
| 9 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.58620312 |
| 10 | Abnormality of glycine metabolism (HP:0010895) | 4.58620312 |
| 11 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.57305053 |
| 12 | Dysostosis multiplex (HP:0000943) | 4.11660102 |
| 13 | Eczematoid dermatitis (HP:0000976) | 3.95593590 |
| 14 | Axonal loss (HP:0003447) | 3.86301610 |
| 15 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.80112759 |
| 16 | Myositis (HP:0100614) | 3.68980786 |
| 17 | Recurrent abscess formation (HP:0002722) | 3.65137684 |
| 18 | Increased connective tissue (HP:0009025) | 3.63834904 |
| 19 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.59654479 |
| 20 | Insulin resistance (HP:0000855) | 3.56716959 |
| 21 | Myoglobinuria (HP:0002913) | 3.56346951 |
| 22 | Pigmentary retinal degeneration (HP:0001146) | 3.53468860 |
| 23 | Abnormality of macrophages (HP:0004311) | 3.52704454 |
| 24 | Recurrent bacterial skin infections (HP:0005406) | 3.49741603 |
| 25 | Epidermoid cyst (HP:0200040) | 3.45012048 |
| 26 | Long foot (HP:0001833) | 3.41987717 |
| 27 | Increased cerebral lipofuscin (HP:0011813) | 3.41745381 |
| 28 | Multiple enchondromatosis (HP:0005701) | 3.40033450 |
| 29 | Growth hormone excess (HP:0000845) | 3.37244153 |
| 30 | Hypoalphalipoproteinemia (HP:0003233) | 3.34717957 |
| 31 | Orchitis (HP:0100796) | 3.33255270 |
| 32 | Subcapsular cataract (HP:0000523) | 3.32340690 |
| 33 | Increased muscle lipid content (HP:0009058) | 3.32217669 |
| 34 | Broad metatarsal (HP:0001783) | 3.31944249 |
| 35 | Myocardial infarction (HP:0001658) | 3.29941016 |
| 36 | Abnormality of proline metabolism (HP:0010907) | 3.24979958 |
| 37 | Hydroxyprolinuria (HP:0003080) | 3.24979958 |
| 38 | Loss of speech (HP:0002371) | 3.18205624 |
| 39 | Vacuolated lymphocytes (HP:0001922) | 3.17439266 |
| 40 | Hyperlipoproteinemia (HP:0010980) | 3.15109213 |
| 41 | Hemorrhage of the eye (HP:0011885) | 3.14884759 |
| 42 | Hypoglycemic coma (HP:0001325) | 3.14012970 |
| 43 | Ketoacidosis (HP:0001993) | 3.13381012 |
| 44 | Nausea (HP:0002018) | 3.09452973 |
| 45 | Ankle contracture (HP:0006466) | 3.09325718 |
| 46 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.04740909 |
| 47 | Type 1 muscle fiber predominance (HP:0003803) | 3.04183482 |
| 48 | Bone cyst (HP:0012062) | 3.04083605 |
| 49 | Hepatosplenomegaly (HP:0001433) | 3.03337469 |
| 50 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.03033867 |
| 51 | Mutism (HP:0002300) | 3.00340362 |
| 52 | Ketosis (HP:0001946) | 2.98476082 |
| 53 | Cerebral aneurysm (HP:0004944) | 2.97205667 |
| 54 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.91761956 |
| 55 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.91761956 |
| 56 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.91761956 |
| 57 | Spontaneous hematomas (HP:0007420) | 2.85699501 |
| 58 | Asymmetric septal hypertrophy (HP:0001670) | 2.85044289 |
| 59 | Obstructive lung disease (HP:0006536) | 2.84247478 |
| 60 | Chronic obstructive pulmonary disease (HP:0006510) | 2.84247478 |
| 61 | Mediastinal lymphadenopathy (HP:0100721) | 2.82775600 |
| 62 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.82211879 |
| 63 | Hyperglycinemia (HP:0002154) | 2.80969365 |
| 64 | Increased variability in muscle fiber diameter (HP:0003557) | 2.80475690 |
| 65 | Hyperthyroidism (HP:0000836) | 2.79666644 |
| 66 | Polycythemia (HP:0001901) | 2.78141266 |
| 67 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.77233482 |
| 68 | Mucopolysacchariduria (HP:0008155) | 2.77233482 |
| 69 | Muscle fiber splitting (HP:0003555) | 2.73700878 |
| 70 | Spinal rigidity (HP:0003306) | 2.68700439 |
| 71 | Skin nodule (HP:0200036) | 2.67793467 |
| 72 | Large hands (HP:0001176) | 2.67216421 |
| 73 | Polyphagia (HP:0002591) | 2.65190379 |
| 74 | Xanthomatosis (HP:0000991) | 2.64043854 |
| 75 | Colitis (HP:0002583) | 2.62854209 |
| 76 | Glomerulonephritis (HP:0000099) | 2.61567072 |
| 77 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.60616296 |
| 78 | Optic neuritis (HP:0100653) | 2.60427447 |
| 79 | Retrobulbar optic neuritis (HP:0100654) | 2.60427447 |
| 80 | Rhabdomyolysis (HP:0003201) | 2.60154621 |
| 81 | Stomatitis (HP:0010280) | 2.60052294 |
| 82 | Increased IgE level (HP:0003212) | 2.59484953 |
| 83 | Abnormal cartilage morphology (HP:0002763) | 2.57205154 |
| 84 | Follicular hyperkeratosis (HP:0007502) | 2.55988770 |
| 85 | Systemic lupus erythematosus (HP:0002725) | 2.54894735 |
| 86 | Disinhibition (HP:0000734) | 2.54681759 |
| 87 | Thyroid-stimulating hormone excess (HP:0002925) | 2.54462187 |
| 88 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.52033173 |
| 89 | Hyperpituitarism (HP:0010514) | 2.51906165 |
| 90 | Gingivitis (HP:0000230) | 2.51851065 |
| 91 | Pancreatitis (HP:0001733) | 2.48900276 |
| 92 | Amyloidosis (HP:0011034) | 2.44471537 |
| 93 | Nuclear cataract (HP:0100018) | 2.43480074 |
| 94 | Purpura (HP:0000979) | 2.41068515 |
| 95 | Toxemia of pregnancy (HP:0100603) | 2.40720033 |
| 96 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.39455675 |
| 97 | Keratoconjunctivitis sicca (HP:0001097) | 2.38069760 |
| 98 | Increased serum ferritin (HP:0003281) | 2.38045995 |
| 99 | Hyperammonemia (HP:0001987) | 2.37978845 |
| 100 | Pulmonary infiltrates (HP:0002113) | 2.35914826 |
| 101 | Accelerated skeletal maturation (HP:0005616) | 2.35111116 |
| 102 | Abnormal hemoglobin (HP:0011902) | 2.34359279 |
| 103 | Hematochezia (HP:0002573) | 2.33950882 |
| 104 | * Abnormality of complement system (HP:0005339) | 2.33756968 |
| 105 | Vertebral compression fractures (HP:0002953) | 2.32061775 |
| 106 | Hypercholesterolemia (HP:0003124) | 2.31036478 |
| 107 | Hemoptysis (HP:0002105) | 2.30633276 |
| 108 | Hyporeflexia of lower limbs (HP:0002600) | 2.30519331 |
| 109 | Right ventricular cardiomyopathy (HP:0011663) | 2.29367287 |
| 110 | Facial diplegia (HP:0001349) | 2.28639404 |
| 111 | Decreased subcutaneous fat (HP:0001002) | 2.28108511 |
| 112 | Lipoatrophy (HP:0100578) | 2.26457382 |
| 113 | Malnutrition (HP:0004395) | 2.25830280 |
| 114 | Aortic aneurysm (HP:0004942) | 2.24835736 |
| 115 | Autoimmune thrombocytopenia (HP:0001973) | 2.23980712 |
| 116 | Enlarged penis (HP:0000040) | 2.23676962 |
| 117 | Polygenic inheritance (HP:0010982) | 2.23634651 |
| 118 | Cellulitis (HP:0100658) | 2.22936912 |
| 119 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.22634722 |
| 120 | Prenatal maternal abnormality (HP:0002686) | 2.21920976 |
| 121 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.21443568 |
| 122 | Dicarboxylic aciduria (HP:0003215) | 2.21443568 |
| 123 | Venous abnormality (HP:0002624) | 2.18648270 |
| 124 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.18537418 |
| 125 | Slender build (HP:0001533) | 2.17193922 |
| 126 | Hyperglycemia (HP:0003074) | 2.16503789 |
| 127 | Thrombocytosis (HP:0001894) | 2.15540941 |
| 128 | Progressive neurologic deterioration (HP:0002344) | 2.14862891 |
| 129 | Polar cataract (HP:0010696) | 2.13455948 |
| 130 | Tetraparesis (HP:0002273) | 2.13337718 |
| 131 | Keratoconjunctivitis (HP:0001096) | 2.13231794 |
| 132 | Aortic dissection (HP:0002647) | 2.12671121 |
| 133 | Petechiae (HP:0000967) | 2.12183108 |
| 134 | Meningitis (HP:0001287) | 2.12121278 |
| 135 | Prolonged bleeding time (HP:0003010) | 2.09851166 |
| 136 | Neurofibrillary tangles (HP:0002185) | 2.08727482 |
| 137 | Prominent supraorbital ridges (HP:0000336) | 2.07656810 |
| 138 | Vasculitis (HP:0002633) | 2.07113111 |
| 139 | Abnormality of purine metabolism (HP:0004352) | 2.06175675 |
| 140 | Shallow orbits (HP:0000586) | 2.06011026 |
| 141 | Muscle stiffness (HP:0003552) | 2.05274966 |
| 142 | Premature rupture of membranes (HP:0001788) | 2.04137458 |
| 143 | Recurrent skin infections (HP:0001581) | 2.03869147 |
| 144 | Inflammation of the large intestine (HP:0002037) | 2.03433443 |
| 145 | Joint stiffness (HP:0001387) | 2.02355864 |
| 146 | Hypercortisolism (HP:0001578) | 2.01789863 |
| 147 | Turricephaly (HP:0000262) | 2.00711843 |
| 148 | Neck muscle weakness (HP:0000467) | 2.00294902 |
| 149 | Abnormality of subcutaneous fat tissue (HP:0001001) | 2.00025941 |
| 150 | Abnormality of iron homeostasis (HP:0011031) | 1.99744276 |
| 151 | Myotonia (HP:0002486) | 1.99477728 |
| 152 | Abnormal eating behavior (HP:0100738) | 1.99049836 |
| 153 | Glomerulopathy (HP:0100820) | 1.98920501 |
| 154 | * Complement deficiency (HP:0004431) | 1.98103084 |
| 155 | Gastrointestinal inflammation (HP:0004386) | 1.95096762 |
| 156 | Hypergammaglobulinemia (HP:0010702) | 1.94988670 |
| 157 | Rectal prolapse (HP:0002035) | 1.94955793 |
| 158 | Chest pain (HP:0100749) | 1.94850107 |
| 159 | Ragged-red muscle fibers (HP:0003200) | 1.94445896 |
| 160 | Interstitial pulmonary disease (HP:0006530) | 1.92708954 |
| 161 | Stridor (HP:0010307) | 1.91629766 |
| 162 | Pathologic fracture (HP:0002756) | 1.90634968 |
| 163 | Recurrent fungal infections (HP:0002841) | 1.89711201 |
| 164 | Epistaxis (HP:0000421) | 1.85885680 |
| 165 | Episodic fever (HP:0001954) | 1.85685263 |
| 166 | Proximal amyotrophy (HP:0007126) | 1.85578643 |
| 167 | Protrusio acetabuli (HP:0003179) | 1.84455399 |
| 168 | Hypertensive crisis (HP:0100735) | 1.84384928 |
| 169 | Polyneuropathy (HP:0001271) | 1.83199211 |
| 170 | Urticaria (HP:0001025) | 1.81888064 |
| 171 | Aneurysm (HP:0002617) | 1.80386890 |
| 172 | Buphthalmos (HP:0000557) | 1.75049100 |
| 173 | Striae distensae (HP:0001065) | 1.74107548 |
| 174 | Ileus (HP:0002595) | 1.72412946 |
| 175 | Generalized aminoaciduria (HP:0002909) | 1.70438265 |
| 176 | Fibular hypoplasia (HP:0003038) | 1.69587561 |
| 177 | Ectopia lentis (HP:0001083) | 1.66892262 |
| 178 | Limb hypertonia (HP:0002509) | 1.66294423 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMK1D | 6.22855640 |
| 2 | TRIB3 | 5.54106640 |
| 3 | SIK1 | 4.59732189 |
| 4 | CAMK1G | 4.56930343 |
| 5 | BCKDK | 3.99567982 |
| 6 | RIPK4 | 3.28373781 |
| 7 | ERN1 | 2.72313891 |
| 8 | RIPK1 | 2.69645428 |
| 9 | PDK3 | 2.65646288 |
| 10 | PDK4 | 2.65646288 |
| 11 | LMTK2 | 2.54379075 |
| 12 | MST1R | 2.50992981 |
| 13 | BLK | 2.31588919 |
| 14 | MAP3K11 | 2.19038046 |
| 15 | TBK1 | 2.18905806 |
| 16 | NME2 | 2.15609002 |
| 17 | GRK7 | 2.09357959 |
| 18 | EPHB2 | 1.97547332 |
| 19 | MOS | 1.95336844 |
| 20 | KIT | 1.87653207 |
| 21 | MAP4K1 | 1.86962004 |
| 22 | FES | 1.83138358 |
| 23 | PRKAA2 | 1.79290478 |
| 24 | CDK9 | 1.77741085 |
| 25 | MAP3K3 | 1.64187802 |
| 26 | PRPF4B | 1.64076255 |
| 27 | TAOK1 | 1.63239745 |
| 28 | TAOK2 | 1.58875206 |
| 29 | INSRR | 1.57594864 |
| 30 | MAP3K14 | 1.54739842 |
| 31 | FGFR2 | 1.54240011 |
| 32 | PDK2 | 1.51013757 |
| 33 | FGFR3 | 1.45607363 |
| 34 | PKN2 | 1.42929265 |
| 35 | TESK1 | 1.41721512 |
| 36 | ARAF | 1.40222875 |
| 37 | ZAP70 | 1.38617628 |
| 38 | PDGFRA | 1.34604204 |
| 39 | MAPK4 | 1.31739987 |
| 40 | PIM2 | 1.31143612 |
| 41 | IRAK4 | 1.30061230 |
| 42 | TGFBR2 | 1.26274511 |
| 43 | IKBKB | 1.24122342 |
| 44 | PIK3CA | 1.23606110 |
| 45 | MAP2K1 | 1.21457987 |
| 46 | CDK6 | 1.20052151 |
| 47 | FRK | 1.19779522 |
| 48 | TTN | 1.14068901 |
| 49 | MAP3K1 | 1.11200756 |
| 50 | FGFR4 | 1.09119697 |
| 51 | BTK | 1.09047851 |
| 52 | MET | 1.08628242 |
| 53 | DDR2 | 1.08172426 |
| 54 | IKBKE | 1.07701380 |
| 55 | PHKG1 | 1.07061451 |
| 56 | PHKG2 | 1.07061451 |
| 57 | TIE1 | 1.04864971 |
| 58 | MYLK | 1.02702710 |
| 59 | PRKD3 | 1.01296775 |
| 60 | SYK | 0.99616444 |
| 61 | GRK5 | 0.97533443 |
| 62 | JAK1 | 0.95694885 |
| 63 | LYN | 0.95454048 |
| 64 | FER | 0.94674252 |
| 65 | MAPK7 | 0.93667066 |
| 66 | MAP3K6 | 0.92524153 |
| 67 | KDR | 0.91707722 |
| 68 | HCK | 0.90926342 |
| 69 | LATS1 | 0.90864881 |
| 70 | CDC42BPA | 0.88540749 |
| 71 | PRKAA1 | 0.88032572 |
| 72 | MATK | 0.87712996 |
| 73 | JAK2 | 0.81104486 |
| 74 | DAPK2 | 0.79678404 |
| 75 | FGR | 0.78481891 |
| 76 | PDPK1 | 0.74701665 |
| 77 | RET | 0.70998871 |
| 78 | PRKCH | 0.70839883 |
| 79 | KSR2 | 0.69313636 |
| 80 | LCK | 0.69037686 |
| 81 | ILK | 0.68681247 |
| 82 | LATS2 | 0.68039255 |
| 83 | MAPK15 | 0.67789008 |
| 84 | IGF1R | 0.65509059 |
| 85 | PDGFRB | 0.63212901 |
| 86 | GSK3A | 0.61567212 |
| 87 | MTOR | 0.60975862 |
| 88 | MARK3 | 0.60345400 |
| 89 | TXK | 0.60309655 |
| 90 | EEF2K | 0.59354238 |
| 91 | BMPR2 | 0.58975026 |
| 92 | GRK6 | 0.58058423 |
| 93 | RPS6KL1 | 0.57926450 |
| 94 | RPS6KC1 | 0.57926450 |
| 95 | FLT3 | 0.57184843 |
| 96 | JAK3 | 0.57152335 |
| 97 | NEK9 | 0.57057374 |
| 98 | MAPK11 | 0.56921774 |
| 99 | EPHB1 | 0.56479106 |
| 100 | CSK | 0.56396612 |
| 101 | PRKD1 | 0.56253124 |
| 102 | PKN1 | 0.55519352 |
| 103 | PRKACG | 0.55297428 |
| 104 | CAMKK2 | 0.54209277 |
| 105 | CAMK1 | 0.54023970 |
| 106 | PDK1 | 0.53760761 |
| 107 | PAK2 | 0.53541659 |
| 108 | BMX | 0.53460182 |
| 109 | HIPK2 | 0.52507698 |
| 110 | PTK2B | 0.52043682 |
| 111 | FGFR1 | 0.50601331 |
| 112 | TGFBR1 | 0.50252934 |
| 113 | TEC | 0.49665900 |
| 114 | IRAK3 | 0.49353600 |
| 115 | INSR | 0.48890403 |
| 116 | MAP2K2 | 0.48447289 |
| 117 | CDK4 | 0.48216631 |
| 118 | SIK3 | 0.47442682 |
| 119 | RPS6KA6 | 0.45237799 |
| 120 | TESK2 | 0.44009828 |
| 121 | MAPKAPK2 | 0.43530604 |
| 122 | PRKD2 | 0.42625568 |
| 123 | MAP2K3 | 0.41822198 |
| 124 | MAPKAPK3 | 0.41764207 |
| 125 | MAPK3 | 0.40651570 |
| 126 | STK10 | 0.40289777 |
| 127 | LRRK2 | 0.39242033 |
| 128 | PINK1 | 0.39189021 |
| 129 | MAP2K4 | 0.39069687 |
| 130 | MAPK12 | 0.39047784 |
| 131 | TNK2 | 0.38147819 |
| 132 | MAP2K6 | 0.38124245 |
| 133 | IRAK1 | 0.37546126 |
| 134 | DAPK3 | 0.36993337 |
| 135 | SRC | 0.35560781 |
| 136 | PTK6 | 0.35249954 |
| 137 | MAP3K13 | 0.33613304 |
| 138 | TYRO3 | 0.32601803 |
| 139 | EPHA3 | 0.31404385 |
| 140 | PRKG2 | 0.28933073 |
| 141 | ABL2 | 0.28384713 |
| 142 | IRAK2 | 0.26801366 |
| 143 | PIK3CG | 0.24725109 |
| 144 | RPS6KB1 | 0.23629506 |
| 145 | MARK2 | 0.23557850 |
| 146 | CSF1R | 0.20713089 |
| 147 | DMPK | 0.20541107 |
| 148 | STK3 | 0.20157180 |
| 149 | EIF2AK2 | 0.18081856 |
| 150 | OBSCN | 0.18025652 |
| 151 | TYK2 | 0.17709352 |
| 152 | ABL1 | 0.15651722 |
| 153 | TRPM7 | 0.15491035 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 4.66825031 |
| 2 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 4.64742852 |
| 3 | PPAR signaling pathway_Homo sapiens_hsa03320 | 4.59335850 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.49899262 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.67942444 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 3.51638823 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.36380293 |
| 8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.15592817 |
| 9 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 3.05319041 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.72456611 |
| 11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.67163629 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55200684 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.52712000 |
| 14 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.29942188 |
| 15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.27203962 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.26612270 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 2.25454767 |
| 18 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 2.15932909 |
| 19 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.11648322 |
| 20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.11054601 |
| 21 | Asthma_Homo sapiens_hsa05310 | 2.10255616 |
| 22 | AMPK signaling pathway_Homo sapiens_hsa04152 | 2.05733960 |
| 23 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.01517660 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.97373491 |
| 25 | Allograft rejection_Homo sapiens_hsa05330 | 1.96114857 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.91183366 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.88282596 |
| 28 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.87687244 |
| 29 | Carbon metabolism_Homo sapiens_hsa01200 | 1.71301044 |
| 30 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.69187712 |
| 31 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.68353298 |
| 32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.67987656 |
| 33 | Tuberculosis_Homo sapiens_hsa05152 | 1.59711242 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.52279619 |
| 35 | Peroxisome_Homo sapiens_hsa04146 | 1.46659772 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.44517554 |
| 37 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.40079194 |
| 38 | Insulin resistance_Homo sapiens_hsa04931 | 1.33231506 |
| 39 | Phagosome_Homo sapiens_hsa04145 | 1.30068544 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.26563507 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.26413814 |
| 42 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.25656319 |
| 43 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.25090314 |
| 44 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.23874262 |
| 45 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.23593447 |
| 46 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.22355319 |
| 47 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.20957367 |
| 48 | Salmonella infection_Homo sapiens_hsa05132 | 1.17184772 |
| 49 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.16472446 |
| 50 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.14895328 |
| 51 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.12474162 |
| 52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.11954647 |
| 53 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.10010900 |
| 54 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.08359623 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.07888242 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 1.05899861 |
| 57 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.04692444 |
| 58 | Influenza A_Homo sapiens_hsa05164 | 1.01606842 |
| 59 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.01170571 |
| 60 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.98692478 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.97205735 |
| 62 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.96803344 |
| 63 | Legionellosis_Homo sapiens_hsa05134 | 0.95979149 |
| 64 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.93260594 |
| 65 | Renin secretion_Homo sapiens_hsa04924 | 0.91182484 |
| 66 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.91120382 |
| 67 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.90312608 |
| 68 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.89230337 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89061055 |
| 70 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.87902128 |
| 71 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.85797623 |
| 72 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.83548727 |
| 73 | Histidine metabolism_Homo sapiens_hsa00340 | 0.83052259 |
| 74 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.81536736 |
| 75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.81520013 |
| 76 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.80236076 |
| 77 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79764737 |
| 78 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.79357013 |
| 79 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.77478621 |
| 80 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.76094219 |
| 81 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.74618855 |
| 82 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.72855361 |
| 83 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.72102425 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.68918675 |
| 85 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65766023 |
| 86 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.62155228 |
| 87 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.59765771 |
| 88 | Measles_Homo sapiens_hsa05162 | 0.58790124 |
| 89 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57811439 |
| 90 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57545642 |
| 91 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.54951966 |
| 92 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.53586334 |
| 93 | Apoptosis_Homo sapiens_hsa04210 | 0.53531044 |
| 94 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51967772 |
| 95 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.51395427 |
| 96 | Focal adhesion_Homo sapiens_hsa04510 | 0.51265765 |
| 97 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.47750282 |
| 98 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.47108421 |
| 99 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.46866028 |
| 100 | ABC transporters_Homo sapiens_hsa02010 | 0.46634097 |
| 101 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.45434517 |
| 102 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43455790 |
| 103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42724331 |
| 104 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.42407996 |
| 105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42355229 |
| 106 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.42147390 |
| 107 | Hepatitis B_Homo sapiens_hsa05161 | 0.41592998 |
| 108 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41085782 |
| 109 | Shigellosis_Homo sapiens_hsa05131 | 0.40953432 |
| 110 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.40549229 |
| 111 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.38185379 |
| 112 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.36828123 |
| 113 | Thyroid cancer_Homo sapiens_hsa05216 | 0.36393717 |
| 114 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34844363 |
| 115 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.34730074 |
| 116 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.34575842 |
| 117 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.33072597 |
| 118 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.32798756 |
| 119 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.32570531 |
| 120 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31142925 |
| 121 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.31071383 |
| 122 | Lysine degradation_Homo sapiens_hsa00310 | 0.30900859 |
| 123 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.30640870 |
| 124 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.30581339 |
| 125 | Sulfur relay system_Homo sapiens_hsa04122 | 0.30479902 |
| 126 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.29101273 |
| 127 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.26599191 |
| 128 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.26339040 |
| 129 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.24828434 |
| 130 | Melanoma_Homo sapiens_hsa05218 | 0.23898219 |
| 131 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.23671769 |
| 132 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.23347967 |
| 133 | Amoebiasis_Homo sapiens_hsa05146 | 0.22639828 |
| 134 | Lysosome_Homo sapiens_hsa04142 | 0.20802349 |
| 135 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.19928199 |
| 136 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.19519414 |
| 137 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.17740052 |
| 138 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.16918814 |
| 139 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.16780212 |
| 140 | Salivary secretion_Homo sapiens_hsa04970 | 0.16611533 |
| 141 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.13966853 |
| 142 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.12357472 |
| 143 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.12305718 |
| 144 | Prion diseases_Homo sapiens_hsa05020 | 0.12153220 |
| 145 | Metabolic pathways_Homo sapiens_hsa01100 | 0.10847350 |
| 146 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.10111954 |
| 147 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.08863047 |
| 148 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.08506928 |
| 149 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.07944759 |
| 150 | Hepatitis C_Homo sapiens_hsa05160 | 0.07906043 |
| 151 | Platelet activation_Homo sapiens_hsa04611 | 0.07471974 |
| 152 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.07420082 |
| 153 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.06722003 |
| 154 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.06377002 |
| 155 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.05971170 |
| 156 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.05620513 |
| 157 | Pertussis_Homo sapiens_hsa05133 | 0.04151919 |
| 158 | Glioma_Homo sapiens_hsa05214 | 0.04082129 |

